The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 17, 2019
Filed:
Oct. 29, 2015
Applicant:
Glaxosmithkline Biologicals S.a., Rixensart, BE;
Inventors:
Andrea Carfi, Cambridge, MA (US);
Claudio Ciferri, Oakland, CA (US);
Irmgard Hofmann, Vienna, AT;
Holger Laux, Basel, CH;
Anders Lilja, Vienna, AT;
Yingxia Wen, Acton, MA (US);
Assignee:
GLAXOSMITHKLINE BIOLOGICALS S.A., Rixensart, BE;
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/045 (2006.01); C07K 14/005 (2006.01); A61K 39/00 (2006.01); C12N 5/071 (2010.01); C07K 14/05 (2006.01);
U.S. Cl.
CPC ...
C07K 14/005 (2013.01); A61K 39/00 (2013.01); C12N 5/0682 (2013.01); C12N 2510/02 (2013.01); C12N 2710/16122 (2013.01); C12N 2710/16134 (2013.01); C12N 2710/16151 (2013.01);
Abstract
This invention relates to cytomegalovirus (CMV) proteins suitable for vaccine uses. Provided herein are mammalian host cells, in particular CHO cells, in which the sequence(s) encoding CMV proteins gH, gL, pUL128, pUL130, pUL131 (or a complex-forming fragment thereof) are stably integrated into the genome.